Jianbo Shen
Nantong, 226001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
IMT030122, A novel engineered EpCAM/CD3/4-1BB tri-specific antibody, enhances T-cell recruitment and demonstrates anti-tumor activity in mouse models of colorectal cancer.
Journal: International immunopharmacology
Published: March 30, 2024
Mechanism of Nicotiflorin in San-Ye-Qing rhizome for anti-inflammatory effect in ulcerative colitis.
Mechanism of Nicotiflorin in San-Ye-Qing rhizome for anti-inflammatory effect in ulcerative colitis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 12, 2023
RBM12 regulates the progression of hepatocellular cancer via miR-497-5p/CPNE1 Axis.
Journal: Environmental research
Published: July 24, 2023
Association of ACP5 with the tumor immune microenvironment and its role in cell proliferation and metastasis in pancreatic cancer.
Journal: American journal of translational research
Published: June 21, 2023
Identification of key genes and infiltrating immune cells among acetaminophen-induced acute liver failure and HBV-associated acute liver failure.
Journal: Annals of translational medicine
Published: May 12, 2022
Increased RBM12 expression predicts poor prognosis in hepatocellular carcinoma based on bioinformatics.
Journal: Journal of gastrointestinal oncology
Published: June 23, 2021
The expression and prognostic value of REXO4 in hepatocellular carcinoma.
Journal: Journal of gastrointestinal oncology
Published: February 19, 2021
Low expression of AQP9 and its value in hepatocellular carcinoma.
Journal: Translational cancer research
Published: October 28, 2020
A super-enhancer controls TGF- β signaling in pancreatic cancer through downregulation of TGFBR2.
Journal: Cellular signalling
Published: July 16, 2019
A super-enhancer maintains homeostatic expression of Regnase-1.
Journal: Gene
Published: January 16, 2018
Showing 1-10 of 10
Last Updated: 09/26/2026